Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SMSPHARMA.NSthis companySMS Pharmaceuticals Limited	₹513.20	33.62×	4.36×	3.87×	21.88×	-108.8%	19.7%	14.8%	11.5%	13.0%	8.5%	-2.7%	0.46×	1.86×	5.69×	1.81×	0.1%	4	—	2	C
AARTIDRUGS.NSAarti Drugs Limited	₹499.75	14.97×	1.88×	1.14×	11.19×	-76.9%	29.2%	9.4%	7.6%	12.6%	10.1%	1.7%	0.37×	1.82×	7.19×	1.59×	0.6%	4	3.46	2	C
ALIVUS.NSAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
IOLCP.NSIOL Chemicals and Pharmaceuticals Limited	₹202.95	15.52×	1.19×	0.92×	8.2×	-108.0%	21.7%	8.1%	5.9%	7.7%	6.9%	1.8%	0.08×	0.26×	12.97×	1.78×	1.4%	4	—	2	C
KOPRAN.NSKopran Limited	₹259.76	20.27×	0.98×	0.77×	10.71×	-111.9%	23.4%	8.9%	3.8%	4.9%	6.5%	-2.0%	0.29×	2.33×	5.77×	1.51×	2.8%	5	—	3	B-
MOREPENLAB.NSMorepen Laboratories Limited	₹99.15	21.5×	1.64×	1.13×	12.61×	-82.7%	37.8%	4.9%	5.3%	7.6%	4.7%	-7.1%	0.17×	0.8×	5.43×	2.37×	0.5%	5	5.38	3	B
Peer median	—	20.27×	1.64×	1.13×	11.19×	-82.7%	29.2%	8.9%	5.9%	7.7%	6.9%	1.7%	0.17×	0.8×	7.19×	1.78×	0.6%	5	4.42	3	—